JP2013544272A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544272A5
JP2013544272A5 JP2013541414A JP2013541414A JP2013544272A5 JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5 JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5
Authority
JP
Japan
Prior art keywords
composition
mtc
diluent
direct compression
compressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013541414A
Other languages
English (en)
Japanese (ja)
Other versions
JP6093707B2 (ja
JP2013544272A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2011/001662 external-priority patent/WO2012072977A2/en
Publication of JP2013544272A publication Critical patent/JP2013544272A/ja
Publication of JP2013544272A5 publication Critical patent/JP2013544272A5/ja
Application granted granted Critical
Publication of JP6093707B2 publication Critical patent/JP6093707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013541414A 2010-11-30 2011-11-30 化合物製剤 Active JP6093707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41816410P 2010-11-30 2010-11-30
US61/418,164 2010-11-30
PCT/GB2011/001662 WO2012072977A2 (en) 2010-11-30 2011-11-30 Compound formulations

Publications (3)

Publication Number Publication Date
JP2013544272A JP2013544272A (ja) 2013-12-12
JP2013544272A5 true JP2013544272A5 (enExample) 2016-06-16
JP6093707B2 JP6093707B2 (ja) 2017-03-08

Family

ID=45418703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013541414A Active JP6093707B2 (ja) 2010-11-30 2011-11-30 化合物製剤

Country Status (10)

Country Link
US (1) US9192611B2 (enExample)
EP (1) EP2645994B1 (enExample)
JP (1) JP6093707B2 (enExample)
CN (1) CN103379901B (enExample)
AU (1) AU2011334679B2 (enExample)
CA (1) CA2818068C (enExample)
ES (1) ES2655492T3 (enExample)
MY (1) MY163074A (enExample)
SG (2) SG190406A1 (enExample)
WO (1) WO2012072977A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014153444A (ja) * 2013-02-06 2014-08-25 Konica Minolta Inc 位相差フィルム、偏光板及び液晶表示装置
SI4335517T1 (sl) 2016-07-25 2025-11-28 Taurx Therapeutics Management Ltd. Dajanje in odmerek diaminofenotiazinov
FR3104438B1 (fr) * 2019-12-12 2021-11-19 Univ Bordeaux Formulation pour le bleu de methylene et procede
CA3257856A1 (en) 2022-05-31 2023-12-07 Wista Laboratories Ltd. TREATMENT OF NEURODEGENERATIVE DISORDERS USING COMPOUNDS CONTAINING METHYLTHIONINIUM (MT)
WO2024063700A1 (en) 2022-09-21 2024-03-28 Yin Sze Loh Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880373A (en) 1988-04-28 1989-11-14 The Upjohn Company Tablet press
JPH0840942A (ja) * 1994-07-29 1996-02-13 Kanegafuchi Chem Ind Co Ltd 薬物放出制御製剤
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0106953D0 (en) 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0322756D0 (en) 2003-09-29 2003-10-29 Univ Aberdeen Methods of chemical synthesis
WO2006032879A2 (en) 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
PT1811957E (pt) * 2004-10-19 2009-01-27 Krka Tovarna Zdravil D D Novo Composição farmacêutica sólida contendo cloridrato de donepezil
TW200738281A (en) * 2005-08-24 2007-10-16 Wyeth Corp Bazedoxifene acetate formulations
US20070154545A1 (en) * 2006-01-05 2007-07-05 Julia Hrakovsky Dry formulations of aripiprazole
DE602007008550D1 (de) 2006-03-29 2010-09-30 Wista Lab Ltd 3,7-diamino-10h-phenothiazinsalze und ihre verwendung
US20080317678A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
SI2954932T1 (sl) 2007-10-03 2019-01-31 Wista Laboratories Ltd. Terapevtska uporaba diaminofenotiazinov
EP2227766A2 (en) 2007-11-05 2010-09-15 Wista Laboratories Ltd. Systems for clinical trials
KR101728574B1 (ko) * 2009-09-24 2017-04-19 위스타 레보레이토리스 리미티드 실질적으로 순수한 메틸티오니늄 클로라이드 5수화물 형태 a의 제조 방법

Similar Documents

Publication Publication Date Title
AU2015215000B2 (en) Solid pharmaceutical compositions of androgen receptor antagonists
EP2068839B1 (en) Pharmaceutical compositions comprising nilotinib or its salt
TWI700100B (zh) 用於口服投藥之包含依澤替米貝(ezetimibe)及羅舒伐他汀(rosuvastatin)的複合調配物及其製備方法
KR20150067153A (ko) 티카그렐러를 함유하는 고형의 경구용 약학 제제
US20090018175A1 (en) Pharmaceutical excipient complex
JP2013544272A5 (enExample)
TWI774159B (zh) 含有托格列淨(Tofogliflozin)之固體製劑及其製造方法
KR101230178B1 (ko) 골다공증 예방 또는 치료용 조성물 및 이의 제조방법
JP5415561B2 (ja) Hcvポリメラーゼ阻害剤のプロドラッグを含む医薬組成物
JP2017523149A (ja) エドキサバンの医薬組成物
CN108174596A (zh) 包含8-[(3r)-3-氨基-1-哌啶基]-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[4-甲基-2-喹唑啉基)甲基]-1h-嘌呤-2,6-二酮或其药学上可接受的盐的药物组合物
WO2015022559A1 (en) Pharmaceutical composition containing rosuvastatin and ramipril
EP2946771B1 (en) Water-dispersible tablet formulation comprising deferasirox
JP5755382B2 (ja) 口腔内崩壊錠
CN102423482B (zh) 复方氨氯地平赖诺普利片的制备方法
JP7233852B2 (ja) 変色が抑制された固形製剤
WO2015199115A1 (ja) 経口投与用医薬組成物
EP4279075B1 (en) A pharmaceutical composition comprising elagolix
JP6272328B2 (ja) カンデサルタンシレキセチル含有製剤
GR1009619B (el) Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης
RU2261094C1 (ru) Твердая лекарственная форма для лечения артериальной гипертензии и способ ее изготовления
WO2014002851A1 (ja) 固形医薬錠剤およびその製造方法
JP2013103924A (ja) 結晶性アトルバスタチンカルシウム含有錠剤の製造方法
KR20210105381A (ko) 리팍시민 정제의 제조 방법 및 리팍시민 정제
WO2008008057A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof